Atrial Fibrillation and Stroke: The View from Cardiology

  • James E. Dalen


More than 90% of all systemic emboli, including cerebral emboli, originate as intracardiac thrombi. The cardiovascular disorders that predispose to intracardiac thrombi are valvular heart disease. prosthetic heart valves, myocardial infarction and atrial fibrillation (AF) (1).


Atrial Fibrillation Valvular Heart Disease Arterial Embolism Rheumatic Heart Disease Systemic Embolism 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Dalen JE. Systemic Embolism. In: Rippe JM, Irwin RW, Alpert JS, Dalen JE, eds. Intensive Care Medicine, Little, Brown, Boston, 1985, 209.Google Scholar
  2. 2.
    Abbott WM, Maloney RD, McCabe CC, Lee CE, Wirthlin LS: Arterial embolism: A 44 year perspective. Am J Surg 143:460, 1982.PubMedCrossRefGoogle Scholar
  3. 3.
    Szczepanski KP: Results of surgical treatment of arterial embolism. Scand J Thorac Cardiovasc Surg 13:71, 1979.PubMedCrossRefGoogle Scholar
  4. 4.
    Green RM, DeWeese JA, Rob CG: Arterial embolectomy before and after the Fogarty catheter. Surgery 77:24, 1975.PubMedGoogle Scholar
  5. 5.
    Silvers LW, Royster TS, Mulcare RJ: Peripheral arterial emboli and factors in their recurrence rate. Ann Surg 192:232, 1980.PubMedCrossRefGoogle Scholar
  6. 6.
    Lorentzen JE, Roder OC, Hansen HJB: Peripheral arterial embolism. Acta Chir Scand 502:111, 1980.Google Scholar
  7. 7.
    Satiani B, Evans WE: Immediate prognosis and five year survival after arterial embolectomy following myocardial infarction. Surg Gynecol Obstet 150:41, 1980.PubMedGoogle Scholar
  8. 8.
    Hurst JW, Paulk EA Jr, Proctor HD, Schlant RC: Management of patients with atrial fibrillation. Am J Med 37:728, 1964.PubMedCrossRefGoogle Scholar
  9. 9.
    Hinton RC, Kistler JP, Fallon JT, Friedlich AL, Fisher CM: Influence of etiology of atrial fibrillation on incidence of systemic embolism. Am J Cardiol 40:509, 1977.PubMedCrossRefGoogle Scholar
  10. 10.
    Levine HJ, Pauker SG, Salzman EW: Antithrombotic therapy in valvular heart disease. Chest 89, Feb. Supplement 36S, 1986.Google Scholar
  11. 11.
    Stein PD, Collins JJ Jr, Kantrowitz A: Antithrombotic therapy in mechanical and biological prosthetic heart valves and saphenous vein bypass grafts. Chest 89, Feb. Supplement 46S, 1986.Google Scholar
  12. 12.
    Dunn M, Alexander J, de Silva R, Hildner F: Antithrombotic therapy in atrial fibrillation. Chest 89, Feb. Supplement 68S, 1986.Google Scholar
  13. 13.
    Wolf PA, Dawber TR, Thomas HE Jr, Thomas E Jr, Kanneil WB: Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham study. Neurology 28:973, 1978.PubMedCrossRefGoogle Scholar
  14. 14.
    Sherman DG, Dyken ML, Fisher M, Harrison MJG, Hart RG: Cerebral embolism: Chest 89, Feb. Supplement 82S, 1986.Google Scholar
  15. 15.
    Bar-Sela S, Ehrenfeld M, Eliakim M: Arterial embolism in thyrotoxicosis with atrial fibrillation. Arch Intern Med 141:1191, 1981.PubMedCrossRefGoogle Scholar
  16. 16.
    Yuen RWM, Gutteridge DH, Thompson PL, Robinson JS: Embolism in thyrotoxic atrial fibrillation. Med J Aust 1:630, 1979.PubMedGoogle Scholar
  17. 17.
    Staffurth JS, Gibberd MC, Fui SNT: Arterial embolism in thyrotoxicosis with atrial fibrillation. Br Med J 2:688, 1977.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1987

Authors and Affiliations

  • James E. Dalen
    • 1
  1. 1.University of Massachusetts at WorcesterWorcesterUSA

Personalised recommendations